The EPIQ and Affiniti portfolio - bluemed.sk Affiniti Family.pdf · 2018. 10. 1. · Affiniti 50...

4
EPIQ 7 Affiniti 50 The EPIQ and Affiniti portfolio Our latest, most innovative and seamless ultrasound portfolio designed to meet the changing needs of health care Affiniti It understands your everyday Engineered for efficiency and reliability, Affiniti brings you outstanding image quality, advanced features, and walk-up usability. EPIQ The evolution of premium ultrasound The Philips EPIQ ultrasound system delivers images for a new level of diagnostic confidence with the most powerful architecture ever created for ultrasound. Ultrasound Affiniti 70 EPIQ 5 Increasing capability

Transcript of The EPIQ and Affiniti portfolio - bluemed.sk Affiniti Family.pdf · 2018. 10. 1. · Affiniti 50...

Page 1: The EPIQ and Affiniti portfolio - bluemed.sk Affiniti Family.pdf · 2018. 10. 1. · Affiniti 50 Affiniti 70 High-end EPIQ 5 EPIQ 7 Premium Philips ultrasound portfolio Affiniti 30

EPIQ 7Affiniti 50

The EPIQ and Affiniti portfolioOur latest, most innovative and seamless ultrasound portfolio designed to meet the changing needs of health care

AffinitiIt understands your everyday

Engineered for efficiency and reliability, Affiniti brings you outstanding image quality, advanced features, and walk-up usability.

EPIQThe evolution of premium ultrasound

The Philips EPIQ ultrasound system delivers images for a new level of diagnostic confidence with the most powerful architecture ever created for ultrasound.

Ultrasound

Affiniti 70 EPIQ 5

Increasing capability

The print quality of this copy is not an accurate representation of the original.

Page 2: The EPIQ and Affiniti portfolio - bluemed.sk Affiniti Family.pdf · 2018. 10. 1. · Affiniti 50 Affiniti 70 High-end EPIQ 5 EPIQ 7 Premium Philips ultrasound portfolio Affiniti 30

2

Helps reduce training for staff and productivity loss as sonographers move from system to system. Perfect for clinicians and sonographers moving within an IDN, large and small healthcare network with satellite facilities.

EPIQ and Affiniti share a similar user interface

EPIQ and Affiniti share transducers (20)

* Affiniti 70

Reduce the investment in your EPIQ and Affiniti ultrasound fleet by sharing specialty ultrasound transducers.

EPIQ and Affiniti share transducers (20)

Top five advantages of the EPIQ and Affiniti portfolio

EPIQ and Affiniti share a common DNA with similar architectural platformsSimplicity of service on a common platform allows biomedical efficiency and cost control. Many features developed for EPIQ and Affiniti will be shared: • New technologies• New transducers• Connectivity

• Reporting• Workflow improvements• Security

1

2

3

Transducers that can be shared EPIQ Affiniti* CX50

L12-3 ● ● ●

L12-5 50 ● ● ●

VL13-5 ● ●

L15-7io ● ● ●

eL18-4 PureWave ● ●

L18-5 ● ●

C5-1 PureWave ● ● ●

C9-2 PureWave ● ●

C10-3v PureWave ● ● ●

C8-5 ● ● ●

C10-4ec ● ●

V6-2 ● ●

3D9-3V ● ●

S5-1 PureWave ● ● ●

S7-3t ● ● ●

S8-3 ● ● ●

S8-3t ● ●

S12-4 ● ● ●

X7-2t ● ● ●

X8-2t ●

The print quality of this copy is not an accurate representation of the original.

Page 3: The EPIQ and Affiniti portfolio - bluemed.sk Affiniti Family.pdf · 2018. 10. 1. · Affiniti 50 Affiniti 70 High-end EPIQ 5 EPIQ 7 Premium Philips ultrasound portfolio Affiniti 30

EPIQ and Affiniti

EPIQ and Affiniti are universal platforms offering no-compromise configurabilityUsers can configure their systems with our most advanced capabilities.

• Exceptional clinical performance with any application

• Flexible configuration allows customization to match clinical needs

• Added capabilities expand service or redeploy in another department*

3

1991

1999

1995

20032010

20182014

202219

932001

200819

972005

20122020

20162024

1992

20002007

1996

20042011

20192015

202319

942002

200919

982006

20132021

2017

iE33, iU22, HD11, and HD15HDI and SONOS platform

You arehere

EPIQ introduction:Q4 2013- Q1 2014Affiniti introduction:Q4 2014 -Q1 2015

The average life of a high-end premium ultrasound product is seven to ten years. This new portfolio provides the clinician with a long upgradability life.

EPIQ and Affiniti represent the latest ultrasound portfolio available from Philips

* Dependent upon the system and level of capabilities already purchased

4

5

The print quality of this copy is not an accurate representation of the original.

Page 4: The EPIQ and Affiniti portfolio - bluemed.sk Affiniti Family.pdf · 2018. 10. 1. · Affiniti 50 Affiniti 70 High-end EPIQ 5 EPIQ 7 Premium Philips ultrasound portfolio Affiniti 30

© 2017 Koninklijke Philips N.V. All rights are reserved.Philips reserves the right to make changes in specifications and/or to discontinue any product at any time without notice or obligation and will not be liable for any consequences resulting from the use of this publication. Trademarks are the property of Koninklijke Philips N.V. or their respective owners.

www.philips.com/ultrasound

Printed in The Netherlands.4522 991 29621 * AUG 2017

Summary Advantages of investing in

the EPIQ and Affiniti portfolio

Advantages BenefitsEPIQ and Affiniti share a common DNA with similar architectural platforms

Simplicity of service on a common platform allows biomedical efficiency and cost control

Share a similar user interface Helps reduce training for staff and productivity loss as sonographers move from system to system; perfect for clinicians and sonographers moving within an IDN and large and small healthcare networks with satellite facilities

Share the same transducers Reduces the investment in your EPIQ and Affiniti ultrasound fleet by sharing specialty ultrasound transducers

Universal platforms Accesses our most advanced ultrasound portfolio with flexible configurability to meet your clinical needs and budgetary requirements

Our latest premium and high-end portfolio on the market

Provides the clinician with a long upgrade life

SPARQ CX50

Compact

ClearVue

Value

Lumify

Point-of-care

Affiniti 50 Affiniti 70

High-end

EPIQ 5 EPIQ 7

Premium

Philips ultrasound portfolio

Affiniti 30

The print quality of this copy is not an accurate representation of the original.